Lifeward (LFWD) Revenue Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 47.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.20% |
| Dec 31, 2025 | 32.61% |
| Sep 30, 2025 | 91.22% |
| Jun 30, 2025 | 53.91% |
| Mar 31, 2025 | 79.12% |
| Dec 31, 2024 | 82.46% |
| Sep 30, 2024 | 45.93% |
| Jun 30, 2024 | 67.16% |
| Mar 31, 2024 | 58.93% |
| Dec 31, 2023 | 78.13% |
| Sep 30, 2023 | 80.64% |
| Jun 30, 2023 | -7.11% |
| Mar 31, 2023 | 17.41% |
| Dec 31, 2022 | 22.65% |
| Sep 30, 2022 | -10.46% |
| Jun 30, 2022 | 21.42% |
| Mar 31, 2022 | -17.87% |
| Dec 31, 2021 | -7.69% |
| Sep 30, 2021 | 6.84% |
| Jun 30, 2021 | -6.73% |
| Mar 31, 2021 | -5.89% |
| Dec 31, 2020 | -7.02% |
| Sep 30, 2020 | -24.45% |
| Jun 30, 2020 | -5.98% |
| Mar 31, 2020 | -32.75% |
| Dec 31, 2019 | -9.46% |
| Sep 30, 2019 | -4.12% |
| Jun 30, 2019 | 2.39% |
| Mar 31, 2019 | -8.46% |
| Dec 31, 2018 | 5.73% |
| Sep 30, 2018 | 11.55% |
| Jun 30, 2018 | 42.63% |
| Mar 31, 2018 | 35.48% |
| Dec 31, 2017 | 1.10% |
| Sep 30, 2017 | 3.99% |
| Jun 30, 2017 | 58.93% |
| Dec 31, 2016 | 60.75% |
| Sep 30, 2016 | 50.83% |